Michael York - Insider Trading & Ownership

Entity
Individual
Location
C/O Phasebio Pharmaceuticals, Inc., 1 Great Valley Pkwy., Suite 30, Malvern, PA
Summary
The estimated net worth of Michael York is at least $48.6K dollars as of January 27, 2023. Michael York is the Chief Business Officer of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $48.6K.
All Insider Reports
All Insider Reports

Ownership of Michael York

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MTCR Metacrine, Inc. Chief Business Officer $48.6K Jan 26, 2023
PHASQ PhaseBio Pharmaceuticals Inc VP, Corporate Development May 20, 2021

Insider Transactions Reported by Michael York:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.